Macrogol Eg

Macrogol 3350, the active ingredient in Macrogol Eg, is an osmotic laxative presented as a powder for oral solution for oral use. It treats constipation and prepares the bowel for diagnostic procedures in adults and children.

GNH USA supplies Macrogol Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Macrogol Eg is an osmotic laxative used to manage conditions affecting bowel function.

Constipation: softens stool and promotes regular bowel movements by retaining water in the intestinal lumen. Bowel preparation for colonoscopy: cleanses the colon to improve visibility during endoscopic procedures. Irritable bowel syndrome with constipation: helps alleviate constipation-predominant symptoms and improve stool frequency.

Macrogol Eg may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating or distension - Nausea or mild vomiting - Flatulence or gas - Diarrhea or loose stools - Abdominal cramps or discomfort - Increased thirst

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Marked dehydration requiring medical attention - Allergic reactions such as rash, itching, or swelling - Severe abdominal pain or intestinal perforation - Rectal bleeding or severe gastrointestinal hemorrhage

Before using Macrogol Eg, consider the following safety measures.

Assess renal function: ensure adequate kidney function to handle fluid shifts. Monitor electrolyte status: check serum electrolytes in patients at risk of imbalance. Avoid in bowel obstruction: contraindicated when mechanical blockage is present. Hypersensitivity caution: discontinue if allergic reactions occur. Pediatric dosing: adjust dose carefully under medical supervision. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Macrogol Eg can interact with other medications, influencing safety or efficacy.

Major Interactions (Avoid): - Concomitant osmotic laxatives: risk of severe dehydration and electrolyte loss. - Loop diuretics: may exacerbate electrolyte disturbances. - Anticholinergic agents: can reduce the laxative effect.

Moderate Interactions (Monitor Closely): - NSAIDs: potential for renal impairment when combined. - ACE inhibitors: monitor potassium levels due to additive effects. - Oral rehydration solutions: may alter intended electrolyte balance.